Member Info for VikR

Just remember the days of 2022-2023 when this share was comfortably sitting around 35-45p. Let’s get back to these levels onto double/triple digits where this belongs. Just imagine the graph on the day of a major news release that’s going to be transformational and best of all any time this year.

Hi

I have also messaged the board again today to prompt them into some sort of update, albeit even if negative so they can be honest and transparent with the market. Agreed though you cannot make such massive statements of MOA and breakthrough findings and then disappear for months. Even a commercial soft update would be hugely welcome to us all

The DR-5 funded project kicked off in May and is using optimal related tech to refine the antibody against DR-5. If they get this antibody finessed where others have failed this alone is worthy of a step change in isolation. Given it’s been a few months work must be underway & a team allocated to this important project. One of the many offerings from FAB that can set this SP alight. For the sake of humanity and improving cancer outcomes I sincerely hope they can make this antibody therapeutically correct, able & clinic ready. Then we will have a prosperous company & more importantly something in the formulary destroy these metastatic cancer cells from within.

https://www.irishnews.com/news/business/800000-grant-will-boost-fusion-project-to-develop-new-cancer-antibody-HQQVBMILVJCM7ESNAGYAF6LRTU/

Hi

I messaged the board a few weeks ago and got the message they are working hard in the background on patent registration and other key milestones. Take that as you will but perhaps they are genuinely working hard in the background to sort the housekeeping in advance of commercialisation. I remain in hope as a fellow pharmacist the advancement in therapy in this area makes this an ethical and rewarding investment as well as a sound financial one

As a fellow pharmacist I can appreciate the effort, skill that has gone into optimal. Even if it only partly capable of what they intended to use it for its a technology light years ahead of any competitor, surely has to be on the eyes of big Pharma. Even if no not expect a multitude of deals to land on validation, parent grant and full commercialisation. Good luck ALTHs…